SB 840 - This act provides that when calculating an enrollee's overall contribution to an out-of-pocket max or any cost-sharing requirement under a health benefit plan, a health carrier or pharmacy benefits manager shall include any amounts paid by the enrollee or paid on behalf of the enrollee for any medication for which a generic substitute is not available. Additionally, no health carrier or pharmacy benefits manager shall design benefits in a manner that takes into account the availability of any cost-sharing assistance program for any medication for which a generic drug substitute is not available. The provisions of this act shall apply to health benefit plans entered into, amended, extended, or renewed on or after August 28, 2026. This act is identical to SB 1448 (2026), SB 1327 (2026), HB 2279 (2026), HB 1941 (2026), HB 1681 (2026), HB 79 (2025) and substantially similar to provisions in HCS/HB 1941, 2279, & 1681 (2026), SB 45 (2025), and similar to provisions in SB 187 (2025), SB 512 (2025), SB 1106 (2024), SB 844 (2024), SB 1190 (2024), HCS/HB 442 (2023), HB 1628 (2024), SB 269 (2023), and SB 1031 (2022). TAYLOR MIDDLETON

{"id": "ocd-bill/a3ec2908-1d67-4fdf-ab38-76b18ecda5c7", "session": "2026", "jurisdiction": {"id": "ocd-jurisdiction/country:us/state:mo/government", "name": "Missouri", "classification": "state"}, "from_organization": {"id": "ocd-organization/8ff25b39-cd33-4cee-a2a9-d88b80b2c6fe", "name": "Senate", "classification": "upper"}, "identifier": "SB 840", "title": "SB 840 - This act provides that when calculating an enrollee's overall contribution to an out-of-pocket max or any cost-sharing requirement under a health benefit plan, a health carrier or pharmacy benefits manager shall include any amounts paid by the enrollee or paid on behalf of the enrollee for any medication for which a generic substitute is not available.\r\n\r\n\tAdditionally, no health carrier or pharmacy benefits manager shall design benefits in a manner that takes into account the availability of any cost-sharing assistance program for any medication for which a generic drug substitute is not available.\r\n\r\n\tThe provisions of this act shall apply to health benefit plans entered into, amended, extended, or renewed on or after August 28, 2026.\r\n\r\n\tThis act is identical to SB 1448 (2026), SB 1327 (2026), HB 2279 (2026), HB 1941 (2026), HB 1681 (2026), HB 79 (2025) and substantially similar to provisions in HCS/HB 1941, 2279, & 1681 (2026), SB 45 (2025), and similar to provisions in SB 187 (2025), SB 512 (2025), SB 1106 (2024), SB 844 (2024), SB 1190 (2024), HCS/HB 442 (2023), HB 1628 (2024), SB 269 (2023), and SB 1031 (2022).\r\nTAYLOR MIDDLETON", "classification": ["bill"], "subject": [], "extras": {"MO_BILL_LR": "5302S.01I"}, "created_at": "2025-12-02T22:22:04.970443+00:00", "updated_at": "2026-05-29T20:04:58.135104+00:00", "openstates_url": "https://openstates.org/mo/bills/2026/SB840/", "first_action_date": "2025-12-01T06:00:00+00:00", "latest_action_date": "2026-01-08T06:00:00+00:00", "latest_action_description": "Second Read and Referred S Insurance and Banking Committee", "latest_passage_date": ""}